Logo image of SB1NO.OL

SPAREBANK 1 SOR-NORGE ASA (SB1NO.OL) Stock Fundamental Analysis

OSL:SB1NO - Euronext Oslo - NO0010631567 - Common Stock - Currency: NOK

178.8  -4.4 (-2.4%)

Fundamental Rating

3

Taking everything into account, SB1NO scores 3 out of 10 in our fundamental rating. SB1NO was compared to 96 industry peers in the Banks industry. SB1NO may be in some trouble as it scores bad on both profitability and health. SB1NO is quite expensive at the moment. It does show a decent growth rate. SB1NO also has an excellent dividend rating.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

In the past year SB1NO was profitable.
SB1NO had a negative operating cash flow in the past year.
SB1NO had positive earnings in each of the past 5 years.
SB1NO had negative operating cash flow in 4 of the past 5 years.
SB1NO.OL Yearly Net Income VS EBIT VS OCF VS FCFSB1NO.OL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5B -5B -10B -15B

1.2 Ratios

Looking at the Return On Assets, with a value of 1.11%, SB1NO is in the better half of the industry, outperforming 75.00% of the companies in the same industry.
SB1NO has a Return On Equity (9.99%) which is in line with its industry peers.
Industry RankSector Rank
ROA 1.11%
ROE 9.99%
ROIC N/A
ROA(3y)1.05%
ROA(5y)0.94%
ROE(3y)11.21%
ROE(5y)10.14%
ROIC(3y)N/A
ROIC(5y)N/A
SB1NO.OL Yearly ROA, ROE, ROICSB1NO.OL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2 4 6 8 10

1.3 Margins

The Profit Margin of SB1NO (41.04%) is better than 92.71% of its industry peers.
SB1NO's Profit Margin has been stable in the last couple of years.
SB1NO does not have Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) 41.04%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y0.81%
PM growth 5Y-1.22%
GM growth 3YN/A
GM growth 5YN/A
SB1NO.OL Yearly Profit, Operating, Gross MarginsSB1NO.OL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40

0

2. Health

2.1 Basic Checks

SB1NO does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for SB1NO has been increased compared to 1 year ago.
Compared to 5 years ago, SB1NO has more shares outstanding
Compared to 1 year ago, SB1NO has about the same debt to assets ratio.
SB1NO.OL Yearly Shares OutstandingSB1NO.OL Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M
SB1NO.OL Yearly Total Debt VS Total AssetsSB1NO.OL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100B 200B 300B 400B

2.2 Solvency

A Debt/Equity ratio of 3.84 is on the high side and indicates that SB1NO has dependencies on debt financing.
The Debt to Equity ratio of SB1NO (3.84) is worse than 79.17% of its industry peers.
Industry RankSector Rank
Debt/Equity 3.84
Debt/FCF N/A
Altman-Z N/A
ROIC/WACCN/A
WACC4.86%
SB1NO.OL Yearly LT Debt VS Equity VS FCFSB1NO.OL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50B 100B 150B 200B

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A
SB1NO.OL Yearly Current Assets VS Current LiabilitesSB1NO.OL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B 25B

5

3. Growth

3.1 Past

The earnings per share for SB1NO have decreased by -1.93% in the last year.
Measured over the past 5 years, SB1NO shows a small growth in Earnings Per Share. The EPS has been growing by 6.99% on average per year.
SB1NO shows a strong growth in Revenue. In the last year, the Revenue has grown by 20.72%.
Measured over the past years, SB1NO shows a quite strong growth in Revenue. The Revenue has been growing by 11.10% on average per year.
EPS 1Y (TTM)-1.93%
EPS 3Y12.35%
EPS 5Y6.99%
EPS Q2Q%2.58%
Revenue 1Y (TTM)20.72%
Revenue growth 3Y15.76%
Revenue growth 5Y11.1%
Sales Q2Q%32.07%

3.2 Future

The Earnings Per Share is expected to grow by 1.09% on average over the next years.
Based on estimates for the next years, SB1NO will show a quite strong growth in Revenue. The Revenue will grow by 8.39% on average per year.
EPS Next Y-5.65%
EPS Next 2Y-1.16%
EPS Next 3Y1.09%
EPS Next 5YN/A
Revenue Next Year21.02%
Revenue Next 2Y11.14%
Revenue Next 3Y8.39%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
SB1NO.OL Yearly Revenue VS EstimatesSB1NO.OL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 5B 10B
SB1NO.OL Yearly EPS VS EstimatesSB1NO.OL Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 5 10 15

3

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 10.37, the valuation of SB1NO can be described as reasonable.
Based on the Price/Earnings ratio, SB1NO is valued a bit more expensive than the industry average as 69.79% of the companies are valued more cheaply.
SB1NO's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 26.34.
Based on the Price/Forward Earnings ratio of 10.68, the valuation of SB1NO can be described as reasonable.
SB1NO's Price/Forward Earnings ratio is a bit more expensive when compared to the industry. SB1NO is more expensive than 63.54% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 22.19. SB1NO is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 10.37
Fwd PE 10.68
SB1NO.OL Price Earnings VS Forward Price EarningsSB1NO.OL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
SB1NO.OL Per share dataSB1NO.OL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 50 100

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)1.48
EPS Next 2Y-1.16%
EPS Next 3Y1.09%

7

5. Dividend

5.1 Amount

SB1NO has a Yearly Dividend Yield of 4.69%, which is a nice return.
SB1NO's Dividend Yield is comparable with the industry average which is at 5.14.
Compared to an average S&P500 Dividend Yield of 2.40, SB1NO pays a better dividend.
Industry RankSector Rank
Dividend Yield 4.69%

5.2 History

On average, the dividend of SB1NO grows each year by 6.63%, which is quite nice.
Dividend Growth(5Y)6.63%
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

SB1NO pays out 36.52% of its income as dividend. This is a sustainable payout ratio.
SB1NO's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP36.52%
EPS Next 2Y-1.16%
EPS Next 3Y1.09%
SB1NO.OL Yearly Income VS Free CF VS DividendSB1NO.OL Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5B -5B -10B -15B
SB1NO.OL Dividend Payout.SB1NO.OL Dividend Payout, showing the Payout Ratio.SB1NO.OL Dividend Payout.PayoutRetained Earnings

SPAREBANK 1 SOR-NORGE ASA

OSL:SB1NO (6/19/2025, 4:19:56 PM)

178.8

-4.4 (-2.4%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupBanks
GICS IndustryBanks
Earnings (Last)05-08 2025-05-08/bmo
Earnings (Next)08-07 2025-08-07
Inst Owners25.73%
Inst Owner ChangeN/A
Ins Owners0.15%
Ins Owner ChangeN/A
Market Cap67.13B
Analysts74.67
Price Target180.95 (1.2%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 4.69%
Yearly Dividend6.2
Dividend Growth(5Y)6.63%
DP36.52%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-0.62%
Min EPS beat(2)-9.84%
Max EPS beat(2)8.6%
EPS beat(4)2
Avg EPS beat(4)2.37%
Min EPS beat(4)-9.84%
Max EPS beat(4)16.91%
EPS beat(8)4
Avg EPS beat(8)2.73%
EPS beat(12)7
Avg EPS beat(12)8.21%
EPS beat(16)10
Avg EPS beat(16)8.63%
Revenue beat(2)1
Avg Revenue beat(2)1.21%
Min Revenue beat(2)-2.79%
Max Revenue beat(2)5.21%
Revenue beat(4)1
Avg Revenue beat(4)-0.28%
Min Revenue beat(4)-3.36%
Max Revenue beat(4)5.21%
Revenue beat(8)5
Avg Revenue beat(8)8.65%
Revenue beat(12)9
Avg Revenue beat(12)8.96%
Revenue beat(16)13
Avg Revenue beat(16)9.24%
PT rev (1m)5.6%
PT rev (3m)9.17%
EPS NQ rev (1m)0.83%
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0.49%
Revenue NQ rev (1m)1.87%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.96%
Valuation
Industry RankSector Rank
PE 10.37
Fwd PE 10.68
P/S 5.08
P/FCF N/A
P/OCF N/A
P/B 1.24
P/tB 1.34
EV/EBITDA N/A
EPS(TTM)17.24
EY9.64%
EPS(NY)16.74
Fwd EY9.36%
FCF(TTM)-5.57
FCFYN/A
OCF(TTM)-4.99
OCFYN/A
SpS35.22
BVpS144.72
TBVpS133.87
PEG (NY)N/A
PEG (5Y)1.48
Profitability
Industry RankSector Rank
ROA 1.11%
ROE 9.99%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 41.04%
GM N/A
FCFM N/A
ROA(3y)1.05%
ROA(5y)0.94%
ROE(3y)11.21%
ROE(5y)10.14%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y0.81%
PM growth 5Y-1.22%
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover0.03
Health
Industry RankSector Rank
Debt/Equity 3.84
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales 1.63%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score2
WACC4.86%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)1.38%
Cap/Sales(5y)1.45%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-1.93%
EPS 3Y12.35%
EPS 5Y6.99%
EPS Q2Q%2.58%
EPS Next Y-5.65%
EPS Next 2Y-1.16%
EPS Next 3Y1.09%
EPS Next 5YN/A
Revenue 1Y (TTM)20.72%
Revenue growth 3Y15.76%
Revenue growth 5Y11.1%
Sales Q2Q%32.07%
Revenue Next Year21.02%
Revenue Next 2Y11.14%
Revenue Next 3Y8.39%
Revenue Next 5YN/A
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y90.85%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y91.76%
OCF growth 3YN/A
OCF growth 5YN/A